.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #190
Optimizing BPH Care: Insights from Physician-APP Collaboration
with Dr. Arpeet Shah and Nicole Hollander, NP
Learn how Advanced Practice Providers (APPs) can boost workflow efficiency and improve patient experience in your urology practice. In this episode of the BackTable Urology podcast, host Dr. Jose Silva speaks with Dr. Arpeet Shah and advanced practice nurse (APN) Nicole Hollander, about the role of APPs in benign prostate hyperplasia (BPH) patient care.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, September 24). Ep. 190 – Optimizing BPH Care: Insights from Physician-APP Collaboration [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Arpeet Shah
Dr. Arpeet Shah is a urologist at Associate Urological Specialists in Chicago, Illinois.
Nicole Hollander, NP
Nicole Hollander is an advanced practice registered nurse at Associate Urological Specialists in Chicago, Illinois.
Dr. Jose Silva
Dr. Jose Silva is a board certified urologist practicing in Central Florida.
Synopsis
Hollander and Shah discuss the importance of effective APP training and onboarding. Dr. Shah shares his wisdom on structuring an APP program to ensure that new practitioners are educated, compliant, and satisfied; all while helping to address the current urologist shortage. The discussion also covers BPH workflows, effective follow-up, and staying up to date on evolving medical knowledge in the context of innovations such as GreenLight Laser and UroCuff.
Timestamps
00:00 - Introduction
06:58 - Nicole’s APP Journey
07:42 - Training APPs
12:22 - BPH Workflow
21:04 - Deciding on Procedures for BPH
26:40 - Rezum
33:40 - Ensuring APP Clinical Excellence and Compliance
36:34 - APP Career Development and Retention
40:31 - Looking Ahead
This BackTable podcast is sponsored by Boston Scientific’s Urology Division. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world; this includes solutions for Benign Prostatic Hyperplasia or BPH, one of the most prevalent urologic conditions facing men today. [1,2]
Boston Scientific’s RezūmTM Water Vapor Therapy is a minimally invasive BPH treatment that provides urologists with an efficient, durable solution that reduces prostate volume while preserving sexual function. [3,4] With proven efficacy, durability, and lower clinical progression rates than daily medications, AUA guidelines support a shared decision-making process for the consideration of RezūmTM as a first-line treatment and alternative to medications. [3,5,6] Additionally, if insufficiently treated, BPH can negatively
impact bladder function, making earlier intervention valuable for patients. [7] Give your patients an alternative to daily medications and long-lasting BPH relief with Rezum Therapy.
1. AUA Annual Census Report – 2021, https://www.auanet.org/research-and-data/aua-census
2. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016
May 5;2:16031. doi: 10.1038/nrdp.2016.31. PMID: 27147135
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water
vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J
Urol. 2021 Sep;206(3):715-24.
4. Mynderse LA, Hanson D, Robb RA, et al. Rezūm System water vapor treatment for lower urinary tract symptoms/benign prostatic
hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional
renderings. Urology. 2015 Jul;86(1):122-7.
5. Gupta N, Rogers T, Holland B, et al. Three-year treatment outcomes of water vapor thermal therapy (Rezūm System) compared to
doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of
Prostatic Symptoms (MTOPS) Trial. J Urol. 2018 Aug;200(2):405-13.
6. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA
Guideline. J Urol 2021; 206: 806.
7. Mirone V, Imbimbo C, Longo N, Fusco F. The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Eur Uro. 2007, Vol 51
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-1540313-AA MAR 2023
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
